Summit Global Investments Jazz Pharmaceuticals PLC Transaction History

Summit Global Investments

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 08, 2021	SELL	$128.64 - $184.79 $8.73 Million - $12.5 Million	-67,883 Closed	0 $0
Q2 2021 Jan 28, 2022	BUY	$160.2 - $186.42 $10.9 Million - $12.7 Million	67,883 New	67,883 $12.1 Million
Q1 2020 May 14, 2020	SELL	$87.74 - $152.74 $922,586 - $1.61 Million	-10,515 Closed	0 $0
Q4 2019 Feb 13, 2020	BUY	$117.65 - $153.73 $23,765 - $31,053	202 Added 1.96%	10,515 $1.57 Million
Q3 2019 Nov 08, 2019	BUY	$125.18 - $143.24 $175,252 - $200,536	1,400 Added 15.71%	10,313 $1.32 Million
Q2 2019 Aug 16, 2019	SELL	$125.55 - $144.48 $251 - $288	-2 Reduced 0.02%	8,913 $1.27 Million
Q1 2019 May 14, 2019	BUY	$121.81 - $142.95 $111,456 - $130,799	915 Added 11.44%	8,915 $1.27 Million
Q4 2018 Feb 08, 2019	BUY	$115.94 - $166.74 $927,520 - $1.33 Million	8,000 New	8,000 $992,000

512

57.5M

188K

133K

Ticker JAZZ
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 62,680,700
Market Cap $7.71B
Description
Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...

Get notified when there are updates to the investment portfolio of Summit Global Investments, based on Form 13F filings with the SEC.

Stay updated on Summit Global Investments with notifications on news.